Market News
Financial market news for retail investors — clear, concise, and jargon-free.
2127 articles — page 123 of 178
StocksEuropean Stocks Rise as Iran Conflict Continues and Oil Prices Surge
European stocks see a slight increase as oil prices climb amid ongoing tensions in Iran.
EconomyFederal Reserve Holds Rates Amid Persistent Inflation, Cuts Expected Later
The Fed is likely to keep interest rates steady as inflation remains high, with potential cuts in 2026.
StocksJPMorgan Advises Investors to Buy the Dip Amid Rising Oil Prices and Geopolitical Tensions
Despite rising oil prices and market volatility, JPMorgan suggests using recent downturns to invest in equities.
EconomyCiti Predicts Bank of England Will Pause Rate Cuts Amid Energy Concerns
Citi forecasts the Bank of England will keep interest rates steady this week due to rising energy prices.
StocksJapan's Nikkei 225 Declines as Key Sectors Struggle
Japan's stock market closed lower on Monday, led by declines in several sectors including Paper & Pulp.
StocksFoxconn Reports 2.4% Drop in Q4 Profit Amid Weak Margins
Foxconn's Q4 profit fell 2.4%, missing estimates as weak margins in consumer electronics offset strong revenue.
StocksKey China AI GPU Stocks to Monitor as Self-Sufficiency Goals Rise
Morgan Stanley highlights top stocks benefiting from China's AI chip manufacturing ambitions.
CryptoCardano Sees 10% Surge in Value
Cardano's price rises 10% in a day, marking its largest gain since February, while Bitcoin and Ethereum also see increases.
CryptoBitcoin Surges Above $74K Amid Short Liquidations and Geopolitical Tensions
Bitcoin reaches a six-week high as traders cover short positions, despite global tensions affecting markets.
StocksWall Street Analysts' Key Takeaways from the Week
This week, analysts made significant updates on Jefferies, Hims & Hers, and NIO.
StocksAustralia's S&P/ASX 200 Declines 0.39% Amid Sector Losses
Australian shares fell on Monday, led by losses in key sectors, with the S&P/ASX 200 hitting a three-month low.
StocksAkeso Shares Surge as New Cancer Drug Enters Clinical Trials
Akeso's stock rises after its cancer drug candidate receives approval for clinical testing.